MAY 2013
Researchers have revealed genetic mutations that may influence who develops severe adverse response to chemotherapy, known as chemotherapy-induced peripheral neuropathy (CIPN). This discovery can ultimately help doctors to have a better understanding of CIPN and whether or not their patients should move forward with certain cancer treatments.
Publications
- Whole Genome and Transcriptome Sequencing of a B3 Thymoma
- Whole Genome Sequencing in an Autism Multiplex Family
- First Case of Plasmodium knowlesi Infection in a Japanese Traveller Returning From Malaysia
- Characterisation of SNPs Associated With Prostate Cancer in Men of Ashkenazic Descent From the Set of GWAS Identified SNPs: Impact of Cancer Family History and Cumulative SNP Risk Prediction
- The Human Microbiome as a Reservoir of Antimicrobial Resistance
News
- Charlotte Martin: Change Your Diet to Fit Your Jeans and Genes
- Scientists Create Novel Approach to Find RNAs Involved in Long-Term Memory Storage
- Researchers Map Shortcuts Between All Human Genes
- Metagenomics Used to Identify Organisms in Outbreaks of Serious Infectious Disease
- Cloud Computing Helps Pharmaceutical Industry Optimise DNA Sequencing and Trials Data: Study
